11/27
02:47 pm
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/27
06:18 am
fbrx
Forte Biosciences (NASDAQ:FBRX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Forte Biosciences (NASDAQ:FBRX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
11/25
07:19 am
fbrx
Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Low
Report
Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
11/24
04:01 pm
fbrx
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
Medium
Report
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
11/21
01:59 pm
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
08:06 am
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $61.00 price target on the stock.
Low
Report
Forte Biosciences (NASDAQ:FBRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $61.00 price target on the stock.
11/14
09:00 am
fbrx
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
Medium
Report
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
11/3
04:01 pm
fbrx
Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
Medium
Report
Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
10/31
01:03 pm
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Forte Biosciences (NASDAQ:FBRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/3
04:01 pm
fbrx
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
Medium
Report
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
9/15
09:00 am
fbrx
Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
Medium
Report
Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
9/11
06:21 am
fbrx
GenVivo Strengthens Oncology Leadership with Appointment of Noriyuki Kasahara, M.D., Ph.D., as Chief Scientific Officer [Yahoo! Finance]
Medium
Report
GenVivo Strengthens Oncology Leadership with Appointment of Noriyuki Kasahara, M.D., Ph.D., as Chief Scientific Officer [Yahoo! Finance]